Meryl Selig has had a unique Stanford journey. She began as a patient volunteer and then became a patient after being diagnosed with B-cell lymphoma. She underwent chemotherapy and enrolled in a clinical trial for a novel CAR-T cell treatment. She sat down with the Stanford Cancer Institute team to share her transformative experience.
Learn more about our Cancer Clinical Trials: med.stanford.e...
Learn more about the Stanford Cancer Institute: med.stanford.e...
Follow the Stanford Cancer Institute
LinkedIn: / stanford-cancer
Twitter: / stanfordcancer
Subscribe to the Stanford Cancer Institute: / @stanfordcancerinstitute
11 фев 2024
